Abstract:Poster session 3, September 23, 2022, 12:30 PM - 1:30 PMObjective: To determine the profile of fluconazole-resistant Candida isolates (FRCS) and the proportion of erg11 gene mutation in fluconazole-resistant C. albicans (FRCA) isolatesMethodsAfter getting approval from ethics the study was conducted on 150 isolates of FRCS obtained from patients admitted to our tertiary care hospital from September 2019 to December 2021. All the isolates were revived onto Sabouraud dextrose agar (SDA) and identified by Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). Fluconazole-resistance was detected by VITEK 2 automated system. Deoxyribonucleic acid (DNA) of FRCA isolates were extracted by QIAamp DNA Mini kit (Qiagen-51 304, Hilden, Germany) as per manufacturer's instruction. A single primer pair targeting the nucleotide sequence from 1067 to 1576 bp region of erg11 gene was used for amplification as per Xu et al. with minor modification and 500 bp polymerase chain reaction (PCR) products were observed by gel electrophoresis. A positive clinical isolate of FRCA was used as a positive control. The PCR products were purified and subjected to Sanger sequencing with an ABI PRISM DNA analyzer (Applied Biosystems) and mutations were detected by using Mega (version 7) software by comparing with the published GenBank sequence AF153844.1 of C. albicans strain ATCC 28516. Categorical variables were expressed in percentages and continuous variables were expressed in mean (average).ResultsOut of the total of 150 FRCS, the most common fluconazole-resistant agent of candidiasis was C. auris , which was isolated from 60 (40%) cases followed by 24 (16%) isolates of C. glabrata , 19 (12.7%) isolates of C. krusei , 18 (12%) isolates of C. parapsilosis , 17 (11.3%) isolates of C. albicans , 10 (6.7%) isolates of C. tropicalis , and only two (1.3%) isolates of C. guilliermondii . Among these 17 FRCA isolates, 9 isolates were obtained from genital swabs, 5 from blood, and a single isolate each from the perianal swab, ear swab, and sputum. A total of 12 (70.6%) out of 17 FRCA isolates yielded 500 bp region in erg11 gene. Gel electrophoresis image of PCR products of erg11 gene is depicted in Figure 1. Sequencing of these products detected a single missense mutation A1309G (V437I) in one FRCA isolate. Most of the FRCA isolates had an average of 4 silent mutations (observed in 6 isolates) and a single isolate had 6 silent mutations. A total of 8 different silent mutations were observed among FRCA isolates T1296C (83.3%), C1203T (66.7%), A1440G (66.7%), C1302T (50%), T1470C (50%), T1140C (25%), T1110C (16.7%), and T1284C (8.3%).Conclusion C. auris was the most common fluconazole resistant isolate observed, followed by C. glabrata, C. krusei, C. parapsilosis, C. albicans, C. tropicalis , and C. guilliermondii . There were many silent mutations observed in erg11 gene of FRCA isolates and detected only a single missense mutation (V437I). Fluconazole-resistant in FRCA isolates may be due to mechanisms other than the studied one in our region.

ERG11 Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles

Comparative Study on the Partial ERG11 Gene Sequence Between the Yeast and Hyphal Forms of Candida Albicans

ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates

Analysis of ERG11 gene mutations in fluconazole-resistant Candida glabrata strains

Relationship Between Antifungal Resistance of Fluconazole Resistant Candida Albicans and Mutations in Erg11 Gene

Gene Mutations and Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis.

Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis

The A395T Mutation in ERG11 Gene Confers Fluconazole Resistance in Candida tropicalis Causing Candidemia

[Molecular Mechanisms of Fluconazole Resistance in Clinical Isolates of Candida Glabrata].

Hotspot Mutations and Genomic Expansion of ERG11 Are Major Mechanisms of Azole Resistance in Environmental and Human Commensal Isolates of Candida Tropicalis.

Correlation Between Azole Susceptibilities, Genotypes, and ERG11 Mutations in Candida Albicans Isolates Associated with Vulvovaginal Candidiasis in China

Investigating role of positively selected genes and mutation sites of ERG11 in drug resistance of Candida albicans

Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase

High‐Resolution Melting Assay to Detect the Mutations That Cause the Y132F and G458S Substitutions at the ERG11 Gene Involved in Azole Resistance in Candida parapsilosis

The relationship between ERG11 gene mutation of Candida albicans and fluconazole-resistance

Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis

K143R Amino Acid Substitution in 14-α-Demethylase (Erg11p) Changes Plasma Membrane and Cell Wall Structure of Candida albicans

P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates

Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris

Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost

Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles